Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 145.60
Bid: 146.20
Ask: 146.80
Change: 2.60 (1.82%)
Spread: 0.60 (0.41%)
Open: 142.60
High: 146.60
Low: 142.60
Prev. Close: 143.00
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM / Interim Management Statement

22 Apr 2015 07:00

ELEMENTIS PLC - AGM / Interim Management Statement

ELEMENTIS PLC - AGM / Interim Management Statement

PR Newswire

London, April 21

22 April 2015 Elementis plc - AGM / Interim Management Statement Elementis plc (ELM.L, the "Company" or the "Group"), the Global SpecialtyChemicals Company, today issues its Interim Management Statement for the threemonths ended 31 March 2015. Commenting on the Company's performance Group Chief Executive, David Dutro,said: "Despite subdued global economic activity,the Elementis team hasdelivered encouraging results in the first quarter of 2015 and we remainconfident in the Group's prospects for the coming year. Moving forward ourstrategy is clear and focused on delivering long-term shareholder value. Weremain resolute in our commitment to outperform our competitors by providinginnovative products and solutions that make our customers more successful. Wehave continued to invest in the future growth of our Specialty Productsbusiness andalthough we are currently in the phase of absorbing the additionalrelated costs,these investmentsare the building blocks of an exciting future". CurrencyConsistent with the Group's Final Results statement in February this year,currency movements reduced Group sales for the first quarter by 5 per centcompared to the same period last year, however, operating profit was impactedby less than 1 per cent, assisted by the Group's hedging programme. In order toprovide a clearer understanding of the Group's underlying performance thefollowing business commentaries focus on constant currency sales ("CC sales"). In Specialty Products, CC sales in the first quarter were 3 per cent higherthan the same period last year and operating margins improved by 50 basispoints, assisted by currency movements. * In coatings additives, CC sales in North America were 4 per cent higher than the previous year, with good growth in decorative coatings as a result of new innovative products from the recently commissioned facility in New Martinsville. Sales in Latin America were 9 per cent higher as the business continued to successfully expand sales outside of Brazil. Sales in Asia Pacific were 5 per cent higher, benefiting from ongoing market share gains in China and good progress in other countries. In Europe, despite relatively subdued economic activity, sales grew by 5 per cent due to new product launches in decorative applications and market share gains. * In personal care, CC sales were 6 per cent higher than the same period last year with good growth in North America, Asia Pacific and Latin America. The business team continues to successfully expand the business both geographically and through new product introductions. * As anticipated, CC sales in oilfield were 13 per cent lower than the first quarter of 2014, as lower oil prices impacted on drilling activity across most of the customer base. In Chromium, there was no significant currency translation impact on sales andoperating profit. Sales volumes in the first quarter were 7 per cent lower thanthe same period last year as demand for refractory grade chrome oxide, whichwas particularly strong in 2014, returned to more normal levels following thecompletion of a number of significant customer projects. Otherwise sales inleather tanning and timber treatment continued to show good growth. Fixed costsin the period benefited from plant optimisation activities and the positiveresolution of some legacy issues. While markets outside of North Americacontinue to be challenging, management expects a full year result that is inline with the business's stated strategy of "stable earnings and cash flow". The Group's balance sheet remains strong and is expected to be in a net cashposition at the end of the year which, under our current special dividendpolicy, will continue to provide shareholders with attractive returns. ENDS Enquiries: Elementis + 44 (0) 207 408 9300David Dutro, Chief ExecutiveBrian Taylorson, Finance Director FTI Consulting + 44 (0) 203 727 1000Deborah ScottMatthew Cole
Date   Source Headline
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing
14th Mar 20237:30 amRNSDirector Declaration
9th Mar 20232:50 pmRNSDirector/PDMR Shareholding
9th Mar 20232:47 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSPreliminary results year ended 31 December 2022
1st Mar 20239:53 amRNSBlock listing Interim Review
1st Mar 20239:39 amRNSTotal Voting Rights
31st Jan 20233:04 pmRNSSale of Chromium business
19th Jan 20237:00 amRNSTrading Update
3rd Jan 20239:47 amRNSTotal Voting Rights
8th Dec 20222:10 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSSale of Chromium business
23rd Nov 20223:54 pmRNSHolding(s) in Company
16th Nov 20221:43 pmRNSHolding(s) in Company
10th Nov 20229:40 amRNSHolding(s) in Company
10th Nov 20227:00 amRNSDirectorate Change
1st Nov 20229:48 amRNSTotal Voting Rights
31st Oct 20223:23 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSQ3 Trading Update
18th Oct 20223:13 pmRNSHolding(s) in Company
3rd Oct 20229:39 amRNSTotal Voting Rights
29th Sep 202212:45 pmRNSDirector/PDMR Shareholding
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
22nd Sep 202211:17 amRNSDirector/PDMR Shareholding
21st Sep 20224:58 pmRNSDirector/PDMR Shareholding
21st Sep 20223:48 pmRNSDirector/PDMR Shareholding
6th Sep 202212:52 pmRNSDirector Declaration
5th Sep 20224:14 pmRNSAdditional Listing
1st Sep 202212:39 pmRNSHolding(s) in Company
1st Sep 20229:15 amRNSBlock listing Interim Review
1st Sep 20229:00 amRNSTotal Voting Rights
2nd Aug 20227:00 amRNSHalf-year Report
1st Aug 202211:08 amRNSTotal Voting Rights
21st Jul 20223:14 pmRNSHolding(s) in Company
1st Jul 20229:47 amRNSTotal Voting Rights
20th Jun 20221:54 pmRNSHolding(s) in Company
17th Jun 20224:35 pmRNSPrice Monitoring Extension
3rd May 202210:27 amRNSTotal Voting Rights
3rd May 20227:00 amRNSCompany Secretary Change
26th Apr 202212:28 pmRNSResult of AGM
26th Apr 20227:00 amRNSAGM Trading Statement
5th Apr 20224:17 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:52 pmRNSAdditional Listing
22nd Mar 20224:18 pmRNSAnnual Financial Report & Notice of AGM
15th Mar 20227:53 amRNSDirectorate Change
8th Mar 202212:18 pmRNSDirector/PDMR Shareholding
8th Mar 202212:17 pmRNSDirector/PDMR Shareholding
8th Mar 202211:47 amRNSHolding(s) in Company
8th Mar 202210:43 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.